Lactobacillus acidophilus NCFM
Natural health product licensed in Canada
- Licence holder
- Danisco USA Inc.
- NPN or DIN-HM
- 80096792
- Status
- Active licence
- Licence date
- 23 January 2020
- Revision date
- 7 February 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : Cellule entière | 20 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : NCFM strain | 20 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Phosphate de potassium monobasique, Phosphate de dipotassium, Trehalose, Dioxyde de silicium, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Helps alleviate/reduce moderate to severe abdominal pain in people with IBS/irritable bowel syndrome. Helps alleviate/reduce moderate to severe abdominal pain associated with IBS/irritable bowel syndrome.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have fever, vomiting, bloody diarrhea or severe abdominal pain. Discontinue use and consult a health care practitioner if symptoms of digestive upset occur, worsen, or persist beyond 3 days. Do not use this product if you have an immune-compromised condition.
Source
Official Health Canada record, licence 80096792
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging